Researchers have come up with a novel method of drug delivery: using an adapted commercial inkjet printer to place drugs onto contact lenses.
Explore TEPEZZA® (teprotumumab-trbw) now for your patients with this serious, progressive disease.
TEPEZZA is a trademark owned by or licensed to Horizon.© 2022 Horizon Therapeutics plc P-TEP-US-00805 12/22
Public & Patients
Museum of the Eye